| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 01/12/1994 | EP0374184B1 Cell growth inhibitors and methods of treating cancer and cell proliferative diseases |
| 01/11/1994 | US5278332 Ethers of myoinsitol phosphate for drugs or foods |
| 01/11/1994 | US5278183 Method for the treatment of autoimmune diseases |
| 01/09/1994 | CA2097248A1 Substituted phenylimidazolidines, a process for their preparation, their application as medicaments and pharmaceutical compositions containing them |
| 01/09/1994 | CA2097247A1 Phenylimidazolidines, substituted or not, a process for their preparation, their application as medicaments and pharmaceutical compositions containing them |
| 01/06/1994 | WO1994000444A1 Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis |
| 01/06/1994 | WO1994000442A1 1-aryl(4-o-alkoxyphenyl 1-piperazinyl)-2, -3 or -4 alkanols, process for their preparation and use thereof in the preparation of drugs |
| 01/06/1994 | WO1994000120A1 Chemical compounds |
| 01/06/1994 | CA2139116A1 1-aryl (o-alcoxyphenyl-4 piperazinyl-1)-2, -3 or -4 alcanols, their preparation and their use for the preparation of medications |
| 01/05/1994 | EP0577470A1 2-Amino-N-[[[4-(aminocarbonyl)pyrimidin-2-yl]amino]alkyl]-pyrimidine-4-carboxamide derivates, their preparation and their use in therapeutics |
| 01/05/1994 | EP0577024A1 3,4,5 substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, as well as a medicament containing them |
| 01/05/1994 | EP0576603A1 Pharmaceutical combination for the treatment of prostatic hyperplasia, containing a 5 alpha-reductase inhibitor and an antiandrogen |
| 01/05/1994 | EP0576425A1 Method for inactivating enveloped viruses and sperm |
| 01/05/1994 | CN1023402C Preparation of serotonin antagonists |
| 01/05/1994 | CN1023399C Preparation of 8-substituted-2-aminotetralines |
| 01/04/1994 | US5276057 L-deprenyl for treating immune system dysfunction |
| 01/04/1994 | US5276051 Arylethylamine compounds |
| 01/04/1994 | US5276014 Human growth factor |
| 01/04/1994 | CA2099556A1 2-amino-n-¬¬¬4-(aminocarbonyl)pyrimidin-2-yl|amino|alkyl| pyrimidine-4-carboxamide derivatives, preparation thereof and therapeutical application thereof |
| 01/02/1994 | CA2099445A1 3,4,5-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them |
| 12/29/1993 | EP0575754A1 Pyridyl-1,2,5-oxadiazol-2-oxide-carbonamides for the treatment of NO-dependent disfunctions like angina pectoris and erection disorders |
| 12/29/1993 | EP0575490A1 GnRH ANALOGS |
| 12/29/1993 | EP0575357A1 Human follicle stimulating hormone receptor |
| 12/29/1993 | EP0575311A1 Control of secretion of milk |
| 12/28/1993 | US5273961 Administering IGF-1 before or during but not after renal failure |
| 12/23/1993 | WO1993025574A1 Inhibitors of angiotensin i chymase(s) including human heart chymase |
| 12/23/1993 | WO1993025567A1 Production of recombinant polypeptides by bovine species and transgenic methods |
| 12/23/1993 | WO1993025550A1 Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 12/23/1993 | WO1993025222A1 Stabilized somatotropin for parenteral administration |
| 12/23/1993 | CA2136547A1 Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 12/22/1993 | EP0574726A1 Annelated 1,2,5-oxadiozole-2 oxides and their use as pharmacological agents |
| 12/22/1993 | EP0482124B1 Somatotropin analogs |
| 12/22/1993 | CN1079651A Minimizing progestin associated breakthrough bleeding |
| 12/22/1993 | CN1079649A Imidazolyl-alkenoic acids |
| 12/22/1993 | CN1079648A Imidazolyl-alkenoic acids |
| 12/21/1993 | US5272271 Pyranobenzoxadiazole derivatives |
| 12/21/1993 | US5272163 Therapeutic amides |
| 12/21/1993 | US5272141 Contraceptive and menstrual cycle controlling drug having oncostatic therapeutic properties for treatment of mammary tumors and melanomas, and method therefor |
| 12/19/1993 | CA2098655A1 Bradykinin antagonist peptidic derivatives, process for preparing them and phamaceutical compositions containing same |
| 12/15/1993 | EP0574174A2 Angiotensin II antagonists |
| 12/15/1993 | EP0573829A1 Pyrimidofuroxanes and their use as pharmacological agents |
| 12/15/1993 | CN1079468A Sulfonamide endothelin antagonists |
| 12/15/1993 | CN1079465A Indoles |
| 12/15/1993 | CN1079386A Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses |
| 12/14/1993 | US5270316 Condensed purine derivatives |
| 12/11/1993 | CA2098058A1 Fused 1,2,5-oxadiazole-2-oxides |
| 12/11/1993 | CA2098056A1 Pyrimidofuroxans |
| 12/09/1993 | WO1993024477A1 Chromone derivative and aldose reductase inhibitor containing the same as active ingredient |
| 12/09/1993 | WO1993024142A1 New pharmaceutical uses of krill enzymes |
| 12/09/1993 | WO1993014750A3 Amino acids useful as inhibitors of the advanced glycosylation of proteins |
| 12/09/1993 | CA2306952A1 Method for removing dental plaque |
| 12/08/1993 | EP0573271A1 Angiotensin II antagonists |
| 12/08/1993 | EP0573133A1 Means for transdermal application of Gestoden |
| 12/08/1993 | EP0572560A1 Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology |
| 12/08/1993 | EP0572455A1 Substituted pyridinones and pyrimidinones as angiotensin ii antagonists |
| 12/08/1993 | EP0480983B1 Use of peroxidated lipids for the preparation of medication to be used in the treatment, by local application, of circulation deficiencies |
| 12/06/1993 | CA2097766A1 Pyridyl-1,2,5-oxadiazolecarboxamide-2-oxides |
| 12/04/1993 | CA2097462A1 Angiotensin ii antagonists |
| 12/04/1993 | CA2097460A1 Angiotensin ii antagonists |
| 12/01/1993 | EP0572166A1 New 7beta-substituted-4-aza-5a-androstan-3-ones as 5a-reductase inhibitors |
| 12/01/1993 | EP0572165A1 New 7B-substituted-4-aza-5a-cholestan-ones as 5a-reductase inhibitors |
| 12/01/1993 | EP0572159A1 Medicament for the treatment of vulvar dystrophy or vaginal dryness |
| 12/01/1993 | EP0571795A1 Novel 3-phenyl-1,2,5-oxadiazoles and their use in the treatment of cardiovascular disorders, in particular angina pectoris and erectile dysfunction |
| 12/01/1993 | CN1022914C Process for preparation of 1, 3-disubstituted piperidine derivatives |
| 11/30/1993 | US5266596 L- or DL-threo-3-(3,4-dihydroxyphenyl)serine for the treatment of urinary incontinence |
| 11/30/1993 | US5266595 Method for treatment of cystinuria |
| 11/30/1993 | CA2097258A1 Phenylfuroxans |
| 11/28/1993 | CA2096556A1 Fatty acid treatment |
| 11/25/1993 | WO1993023428A1 Calcium channel blocking polypeptides from filistata hibernalis |
| 11/25/1993 | WO1993023420A1 NEW 7β-SUBSTITUTED-4-AZA-5α-ANDROSTAN-3-ONES AS 5α-REDUCTASE INHIBITORS |
| 11/25/1993 | WO1993023419A1 NEW 7β-SUBSTITUTED-4-AZA-5α-CHOLESTAN-ONES AS 5α-REDUCTASE INHIBITORS |
| 11/25/1993 | WO1993023397A1 4-mercaptoacetylamino-[2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors |
| 11/25/1993 | WO1993023391A1 Substituted indoles and azaindoles as angiotensin ii antagonists |
| 11/25/1993 | WO1993023378A1 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin ii receptor antagonist properties |
| 11/25/1993 | WO1993023375A1 Substituted pyridines, their preparation and pharmaceutical use |
| 11/25/1993 | WO1993023358A1 Alcohols as potassium channel openers and in treatment of urinary incontinence |
| 11/25/1993 | WO1993023069A1 Health supplements containing phyto-oestrogens, analogues or metabolites thereof |
| 11/25/1993 | WO1993023035A2 Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease |
| 11/25/1993 | WO1993023025A1 Transdermal administration of oxybutynin |
| 11/25/1993 | WO1993023020A1 Contraception method using competitive progesterone antagonists and novel compounds useful therein |
| 11/25/1993 | WO1993017684A3 Enantiomeric hydroxylated xanthine compounds |
| 11/25/1993 | DE4216829A1 Pyridyl derivs. with antithrombotic properties |
| 11/25/1993 | DE4216364A1 Pyridyl derivs. with antithrombotic properties |
| 11/25/1993 | CA2135928A1 Alcohols as potassium channel openers and in treatment of urinary incontinence |
| 11/25/1993 | CA2135605A1 Substituted indoles and azaindoles as angiotensin ii antagonists |
| 11/25/1993 | CA2134765A1 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin ii receptor antagonist properties |
| 11/25/1993 | CA2134563A1 Substituted pyridines, their preparation and pharmaceutical use |
| 11/24/1993 | EP0571243A1 Thiochromane derivatives, process for their preparation and pharmaceutical compositions containing them |
| 11/23/1993 | US5264578 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 11/23/1993 | US5264216 Treatment of bacterial infections |
| 11/21/1993 | CA2096616A1 7beta-substituted-4-aza-5alpha-androstan-ones as 5alpha-reductase inhibitors |
| 11/21/1993 | CA2096576A1 7beta-substituted-4-aza-5alpha-cholestan-ones as 5alpha-reductase inhibitors |
| 11/19/1993 | CA2096406A1 Thiochromanic compounds, method of preparation thereof and pharmaceutical compositions containing them |
| 11/18/1993 | EP0569487A1 Endothelin converting enzyme inhibitors |
| 11/17/1993 | CN1078469A Substituted indole, azaindole and tetrahydro-1H-pyrrol pyrrolo |2,3-c¨ pyridin-7-one derivatives |
| 11/16/1993 | US5262518 Infertility treatment, follicle stimulating hormone |
| 11/11/1993 | WO1993021927A1 Minimizing progestin associated breakthrough bleeding |
| 11/11/1993 | WO1993021926A1 Minimizing progestin associated breakthrough bleeding |
| 11/10/1993 | EP0569193A1 N-isoxazole-phenylsulfonamide derivatives and their use as endothelin antagonists |
| 11/09/1993 | US5260341 Product and process for treating bovine mastitis and bovine metritis |